<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04491357</url>
  </required_header>
  <id_info>
    <org_study_id>2020225-8316</org_study_id>
    <nct_id>NCT04491357</nct_id>
  </id_info>
  <brief_title>Prophylactic Infusion of Calcium Gluconate Reducing the Rate of Hypocalcaemia After Total Thyroidectomy</brief_title>
  <official_title>The Use of Prophylactic Infusion of Calcium Gluconate Compared to Placebo in Reducing the Rate of Hypocalcaemia After Total Thyroidectomy: A Double-Blinded, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-total thyroidectomy hypocalcaemia is a common complication with the rate ranging from&#xD;
      13-49% in a meta-analysis. However, the rate in UMMC in 2018 and 2019 were 40% and 23%&#xD;
      respectively. It lead to prolonged hospital stay and patient dissatisfaction in the event of&#xD;
      hypocalcaemia.&#xD;
&#xD;
      Research question: Does prophylactic intravenous calcium infusion reduces the rate of&#xD;
      post-total thyroidectomy hypocalcaemia? This study will conduct in UMMC endocrine surgery&#xD;
      unit with the target population who scheduled for total thyroidectomy in UMMC between&#xD;
      1/6/2020-1/6/2022.&#xD;
&#xD;
      After obtaining consent from participants, they will be randomised into intervention and&#xD;
      placebo group with the ratio of 1:1. Intervention group will receive the intravenous calcium&#xD;
      gluconate infusion and placebo group will receive saline infusion within 4 hour of skin&#xD;
      closure. Both groups will have their serum calcium measure at 6,12,24,36,48-hour mark post&#xD;
      surgery. Both groups will receive same oral calcium supplements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participating patients will be randomised into intervention and placebo arm with 1:1&#xD;
      ratio. Intervention group will receive 1 ampoule of intravenous calcium gluconate within 4&#xD;
      hours of post total thyroidectomy, whereas the placebo group will received 100ml of normal&#xD;
      saline only. Both groups will receive same oral calcium supplements post surgery. Both groups&#xD;
      will have their serum calcium measure at 6,12,24,36,48-hour mark post surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of hypocalcaemia after total thyroidectomy</measure>
    <time_frame>first 48 hours after total thyroidectomy</time_frame>
    <description>To determine whether prophylactic infusion of calcium gluconate reduces the rate of hypocalcaemia after total thyroidectomy compared to placebo treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>first 48 hours after total thyroidectomy</time_frame>
    <description>To determine whether prophylactic infusion of calcium gluconate reduces the length of hospital stay compared to placebo group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypocalcemia</condition>
  <arm_group>
    <arm_group_label>Intervention arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm will receive 1 ampoule of intravenous calcium gluconate within 4 hours of skin closure post total thyroidectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo arm will receive 100ml of normal saline within 4 hours of skin closure post total thyroidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Gluconate</intervention_name>
    <description>Intravenous calcium gluconate within 4 hours of skin closure after total thyroidectomy</description>
    <arm_group_label>Intervention arm</arm_group_label>
    <other_name>Intravenous calcium gluconate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Normal saline within 4 hours of skin closure after total thyroidectomy</description>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18-80 years old&#xD;
&#xD;
          -  Scheduled for total thyroidectomy in UMMC&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Their age outside the range of 18-80&#xD;
&#xD;
          -  Have parathyroid disorders or end stage renal failure&#xD;
&#xD;
          -  On calcium or vitamin D supplements prior to surgery&#xD;
&#xD;
          -  Have deranged calcium homeostasis (outside the normal range of 2.2-2.6 mmol/L)&#xD;
&#xD;
          -  Scheduled for total thyroidectomy plus lymph node dissection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kah Seng Khoo</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Malaya</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kah Seng Khoo</last_name>
    <phone>+60172489272</phone>
    <email>kahseng901209@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Malaya Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kah Seng Khoo</last_name>
      <phone>+60172489272</phone>
      <email>kahseng901209@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Department of Surgery University of Malaya</last_name>
      <phone>03-7967 6695</phone>
      <email>fomadmin@um.edu.my</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 24, 2020</study_first_submitted>
  <study_first_submitted_qc>July 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Malaya</investigator_affiliation>
    <investigator_full_name>Khoo Kah Seng</investigator_full_name>
    <investigator_title>Surgical Resident, Department of Surgery, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hypocalcaemia</keyword>
  <keyword>Total thyroidectomy</keyword>
  <keyword>Calcium gluconate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypocalcemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not to share IPD to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

